Global Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Region: Trend Forecast and Growth Opportunity

Global Rapid Diagnostics market will reach $ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations.

Highlighted with 83 tables and 97 figures, this 183-page report “Global Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Consumables
Analyzers/Instruments

Based on Prescription, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Professional Diagnostics
OTC Based Testing

By Platform, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Immunoassays

Lateral Flow Assays
Serological Assays
Other Immunoassays

Molecular Detection

Polymerase Chain Reaction (PCR)
Other Molecular Detection Tests
Other Platforms

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Blood Glucose Testing
Cardiometabolic Testing
Infectious Disease Testing
COVID-19 Testing
Healthcare-associated Infections (HAI) Testing
Hepatitis Testing
Tropical Diseases Testing
HIV Testing
Influenza Testing
Sexually Transmitted Diseases (STD) Testing
Other Infectious Diseases Testing
Blood Coagulation Testing
Hematology Testing
Cancer Testing
Drug Abuse Testing
Pregnancy & Fertility Testing
Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Hospitals & Clinics
Laboratories
Individuals/Homecare
Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

North America (U.S., Canada, and Mexico)
Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Prescription and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Diagnostics
ACON Laboratories
Becton Dickinson and Co.
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Chembio Diagnostic Systems
Danaher Corp.
F. Hoffmann La Roche Ltd.
GlySens Inc.
Meridian Bioscience Inc.
OraSure Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech Plc

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Frequently Asked Questions about the Global Rapid Diagnostics Market

What is the estimated value of the Global Rapid Diagnostics Market?

The Global Rapid Diagnostics Market was estimated to be valued at $37775.7 Million in 2021.

What is the growth rate of the Global Rapid Diagnostics Market?

The growth rate of the Global Rapid Diagnostics Market is 7.4%, with an estimated value of $77095.6 Million by 2031.

What is the forecasted size of the Global Rapid Diagnostics Market?

The Global Rapid Diagnostics Market is estimated to be worth $77095.6 Million by 2031.

Who are the key companies in the Global Rapid Diagnostics Market?

Key companies in the Global Rapid Diagnostics Market include Abbott Diagnostics, ACON Laboratories, Becton Dickinson and Co., BioMérieux S.A., Bio, Rad Laboratories, Inc., Chembio Diagnostic Systems, Danaher Corp. and GlySens Inc..

Report Attribute	Details
No. of Pages	183
Published	December 2022
Forecast Period	2021 - 2031
Estimated Market Value ( USD ) in 2021	USD 37775.7 Million
Forecasted Market Value ( USD ) by 2031	USD 77095.6 Million
Compound Annual Growth Rate	7.4%
Regions Covered	Global

1 Introduction

1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Market by Product

3.1 Market Overview by Product
3.2 Consumables
3.3 Analyzers/Instruments

4 Segmentation of Global Market by Prescription

4.1 Market Overview by Prescription
4.2 Professional Diagnostics
4.3 OTC Based Testing

5 Segmentation of Global Market by Platform

5.1 Market Overview by Platform
5.2 Immunoassays
5.2.1 Lateral Flow Assays
5.2.2 Serological Assays
5.2.3 Other Immunoassays
5.3 Molecular Detection
5.3.1 Polymerase Chain Reaction (PCR)
5.3.2 Other Molecular Detection Tests
5.4 Other Platforms

6 Segmentation of Global Market by Application

6.1 Market Overview by Application
6.2 Blood Glucose Testing
6.3 Cardiometabolic Testing
6.4 Infectious Disease Testing
6.4.1 COVID-19 Testing
6.4.2 Healthcare-associated Infections (HAI) Testing
6.4.3 Hepatitis Testing
6.4.4 Tropical Diseases Testing
6.4.5 HIV Testing
6.4.6 Influenza Testing
6.4.7 Sexually Transmitted Diseases (STD) Testing
6.4.8 Other Infectious Diseases Testing
6.5 Blood Coagulation Testing
6.6 Hematology Testing
6.7 Cancer Testing
6.8 Drug Abuse Testing
6.9 Pregnancy & Fertility Testing
6.10 Other Applications

7 Segmentation of Global Market by End User

7.1 Market Overview by End User
7.2 Hospitals & Clinics
7.3 Laboratories
7.4 Individuals/Homecare
7.5 Other End Users

8 Segmentation of Global Market by Region

8.1 Geographic Market Overview 2021-2031
8.2 North America Market 2021-2031 by Country
8.2.1 Overview of North America Market
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 European Market 2021-2031 by Country
8.3.1 Overview of European Market
8.3.2 Germany
8.3.3 U.K.
8.3.4 France
8.3.5 Spain
8.3.6 Italy
8.3.7 Netherlands
8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2021-2031 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 Japan
8.4.3 China
8.4.4 Australia
8.4.5 India
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 South America Market 2021-2031 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America Market
8.6 MEA Market 2021-2031 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets

9 Competitive Landscape

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles

Abbott Diagnostics
ACON Laboratories
Becton Dickinson and Co.
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Chembio Diagnostic Systems
Danaher Corp.
F. Hoffmann La Roche Ltd.
GlySens Inc.
Meridian Bioscience Inc.
OraSure Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech Plc

List of Tables

Table 1. Snapshot of Global Rapid Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Global Rapid Diagnostics Market
Table 6. Global Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 7. Global Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 8. Global Rapid Diagnostics Market by Platform, 2021-2031, $ mn
Table 9. Global Rapid Diagnostics Market: Immunoassays by Type, 2021-2031, $ mn
Table 10. Global Rapid Diagnostics Market: Molecular Detection by Type, 2021-2031, $ mn
Table 11. Global Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 12. Global Rapid Diagnostics Market: Infectious Disease Testing by Type, 2021-2031, $ mn
Table 13. Global Rapid Diagnostics Market by End User, 2021-2031, $ mn
Table 14. Global Rapid Diagnostics Market by Region, 2021-2031, $ mn
Table 15. Leading National Rapid Diagnostics Market, 2021 and 2031, $ mn
Table 16. North America Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 17. U.S. Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 18. U.S. Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 19. U.S. Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 20. Canada Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 21. Canada Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 22. Canada Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 23. Mexico Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 24. Mexico Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 25. Mexico Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 26. Europe Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 27. Germany Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 28. Germany Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 29. Germany Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 30. U.K. Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 31. U.K. Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 32. U.K. Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 33. France Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 34. France Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 35. France Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 36. Spain Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 37. Spain Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 38. Spain Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 39. Italy Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 40. Italy Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 41. Italy Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 42. Netherlands Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 43. Netherlands Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 44. Netherlands Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 45. Rapid Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn
Table 46. APAC Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 47. Japan Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 48. Japan Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 49. Japan Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 50. China Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 51. China Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 52. China Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 53. Australia Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 54. Australia Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 55. Australia Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 56. India Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 57. India Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 58. India Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 59. South Korea Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 60. South Korea Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 61. South Korea Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 62. Rapid Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 63. South America Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 64. Argentina Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 65. Argentina Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 66. Argentina Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 67. Brazil Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 68. Brazil Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 69. Brazil Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 70. Chile Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 71. Chile Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 72. Chile Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 73. MEA Rapid Diagnostics Market by Country, 2021-2031, $ mn
Table 74. UAE Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 75. UAE Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 76. UAE Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 77. Saudi Arabia Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 78. Saudi Arabia Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 79. Saudi Arabia Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 80. South Africa Rapid Diagnostics Market by Product, 2021-2031, $ mn
Table 81. South Africa Rapid Diagnostics Market by Prescription, 2021-2031, $ mn
Table 82. South Africa Rapid Diagnostics Market by Application, 2021-2031, $ mn
Table 83. Rapid Diagnostic Analyzers by Vendor
Table 84. Recent Product Launches, 2018-2021
Table 85. Abbott Diagnostics: Company Snapshot
Table 86. Abbott Diagnostics: Business Segmentation
Table 87. Abbott Diagnostics: Product Portfolio

List of Figures

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Rapid Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Rapid Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Global Rapid Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Rapid Diagnostics Market
Figure 13. Breakdown of Global Rapid Diagnostics Market by Product, 2021-2031, % of Revenue
Figure 14. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 15. Global Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn
Figure 16. Global Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn
Figure 17. Breakdown of Global Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue
Figure 18. Global Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%)
Figure 19. Global Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn
Figure 20. Global Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn
Figure 21. Breakdown of Global Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue
Figure 22. Global Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%)
Figure 23. Global Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn
Figure 24. Global Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn
Figure 25. Global Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn
Figure 26. Global Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn
Figure 27. Global Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn
Figure 28. Global Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn
Figure 29. Global Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn
Figure 30. Global Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn
Figure 31. Breakdown of Global Rapid Diagnostics Market by Application, 2021-2031, % of Revenue
Figure 32. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 33. Global Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn
Figure 34. Global Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn
Figure 35. Global Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn
Figure 36. Global Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn
Figure 37. Global Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn
Figure 38. Global Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn
Figure 39. Global Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn
Figure 40. Global Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn
Figure 41. Global Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn
Figure 42. Global Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn
Figure 43. Global Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn
Figure 44. Global Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn
Figure 45. Global Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn
Figure 46. Global Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn
Figure 47. Global Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn
Figure 48. Global Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn
Figure 49. Global Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn
Figure 50. Breakdown of Global Rapid Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 51. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 52. Global Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn
Figure 53. Global Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn
Figure 54. Global Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn
Figure 55. Global Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 56. Global Market Snapshot by Region
Figure 57. Geographic Spread of Worldwide Rapid Diagnostics Market, 2021-2031, % of Sales Revenue
Figure 58. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 59. North American Rapid Diagnostics Market, 2021-2031, $ mn
Figure 60. Breakdown of North America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 61. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 62. U.S. Rapid Diagnostics Market, 2021-2031, $ mn
Figure 63. Canada Rapid Diagnostics Market, 2021-2031, $ mn
Figure 64. Rapid Diagnostics Market in Mexico, 2021-2031, $ mn
Figure 65. European Rapid Diagnostics Market, 2021-2031, $ mn
Figure 66. Breakdown of European Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 67. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 68. Rapid Diagnostics Market in Germany, 2021-2031, $ mn
Figure 69. Rapid Diagnostics Market in U.K., 2021-2031, $ mn
Figure 70. Rapid Diagnostics Market in France, 2021-2031, $ mn
Figure 71. Rapid Diagnostics Market in Spain, 2021-2031, $ mn
Figure 72. Rapid Diagnostics Market in Italy, 2021-2031, $ mn
Figure 73. Rapid Diagnostics Market in Netherlands, 2021-2031, $ mn
Figure 74. Rapid Diagnostics Market in Rest of Europe, 2021-2031, $ mn
Figure 75. Asia-Pacific Rapid Diagnostics Market, 2021-2031, $ mn
Figure 76. Breakdown of APAC Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 77. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 78. Rapid Diagnostics Market in Japan, 2021-2031, $ mn
Figure 79. Rapid Diagnostics Market in China, 2021-2031, $ mn
Figure 80. Rapid Diagnostics Market in Australia, 2021-2031, $ mn
Figure 81. Rapid Diagnostics Market in India, 2021-2031, $ mn
Figure 82. Rapid Diagnostics Market in South Korea, 2021-2031, $ mn
Figure 83. Rapid Diagnostics Market in Rest of APAC, 2021-2031, $ mn
Figure 84. South America Rapid Diagnostics Market, 2021-2031, $ mn
Figure 85. Breakdown of South America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 86. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 87. Rapid Diagnostics Market in Argentina, 2021-2031, $ mn
Figure 88. Rapid Diagnostics Market in Brazil, 2021-2031, $ mn
Figure 89. Rapid Diagnostics Market in Chile, 2021-2031, $ mn
Figure 90. Rapid Diagnostics Market in Rest of South America, 2021-2031, $ mn
Figure 91. Rapid Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 92. Breakdown of MEA Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 93. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 94. Rapid Diagnostics Market in UAE, 2021-2031, $ mn
Figure 95. Rapid Diagnostics Market in Saudi Arabia, 2021-2031, $ mn
Figure 96. Rapid Diagnostics Market in South Africa, 2021-2031, $ mn
Figure 97. Growth Stage of Global Rapid Diagnostics Industry over the Forecast Period

Companies Mentioned

A selection of companies mentioned in this report includes:

Abbott Diagnostics
ACON Laboratories
Becton Dickinson and Co.
BioMérieux S.A.
Bio-Rad Laboratories, Inc.
Chembio Diagnostic Systems
Danaher Corp.
F. Hoffmann La Roche Ltd.
GlySens Inc.
Meridian Bioscience Inc.
OraSure Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech Plc

Methodology

LOADING...

In-depth qualitative analyses include identification and investigation of the following aspects:

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Based on Prescription, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By Platform, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Immunoassays

Molecular Detection

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Geographically, the following regions together with the listed national/local markets are fully investigated:

Selected Key Players:

What is the estimated value of the Global Rapid Diagnostics Market?

What is the growth rate of the Global Rapid Diagnostics Market?

What is the forecasted size of the Global Rapid Diagnostics Market?

Who are the key companies in the Global Rapid Diagnostics Market?

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Global Clinical Diagnostics Market 2021-2031

Global Urinalysis Market 2021-2031 by Product Type (Instruments, Consumables), Test Type (Biochemical, Pregnancy & Fertility, Sediment), Application, End User, and Region: Trend Forecast and Growth Opportunity

Global Immunochemistry Diagnostic Devices And Equipment Market Report 2022

Global Microbiology Diagnostic Devices And Equipment Market Report 2022

Pulmonary Function Testing Devices Market By Product, By Test Type, By Application, By End user: Global Opportunity Analysis and Industry Forecast, 2021-2031